Embryonated chicken eggs remain one of the most efficient and widely used systems for the cultivation of viruses in the production of human and veterinary vaccines, particularly for influenza. The avian embryo offers an ideal, nutrient-rich, and highly susceptible living host system for viral propagation. However, this susceptibility also means that any latent pathogen present in the egg could proliferate alongside the target vaccine virus. Therefore, the use of certified Specific Pathogen-Free (SPF) eggs is mandatory for producing live attenuated and inactivated vaccines intended for administration to humans or valuable livestock, as dictated by global health authorities like the WHO and FDA.
The demand for high-quality SPF eggs fluctuates with global health needs, requiring suppliers who can offer both supreme quality and reliable volume. NILE SPF plays a vital role in this global supply chain, providing industrial quantities of biologically secure substrates to major pharmaceutical companies. Our eggs undergo rigorous selection processes to ensure high fertility and optimal embryo viability, maximizing vaccine yield per egg. By securing the starting material’s integrity, we enable manufacturers to focus on the complex process of vaccine development, knowing the biological foundation of their product is secure.
